Nephropathy News and Research

RSS

Nephropathy is a broad medical term used to denote disease or damage of the kidney, which can eventually result in kidney failure. The primary and most obvious functions of the kidney are to excrete any waste products and to regulate the water and acid-base balance of the body – therefore loss of kidney function is a potentially fatal condition.

REDDSTAR plenary meeting to be held in Berlin on Nov 5 and 6

'Diabetes- can stem cells help?' is a free, public event that will be held on Monday, 4 November 2013 from 19:00- 20:30 at The Ruin located within the Berlin Museum of Medical History, Charité. Diabetes and stem cell researchers from around Europe will assemble for a REDDSTAR plenary meeting hosted by Charité in Berlin on November 5 and 6th.

30 Oct 2013

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced the acquisition of patents for DJ5, a novel non-TZD PPARgamma agonist with potential to retard progressive renal failure in patients with autosomal dominant polycystic kidney disease ("ADPKD').

29 Oct 2013

Pharmalink's Busulipo receives FDA orphan drug designation

Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces its product Busulipo, a best-in-class conditioning agent for use in cancer patients prior to hematopoietic stem cell transplantation (HSCT; also known as bone marrow transplantation), has received orphan drug designation from the US Food and Drug Administration.

29 Oct 2013

Study examines role of urate-lowering therapy on renal function in patients with hyperuricemia

Urate-lowering therapy alone may not directly reduce the risk of kidney disease in those with hyperuricemia. However, according to a study presented at the American College of Rheumatology Annual Meeting in San Diego, working to lower serum uric acid based on the 2012 American College of Rheumatology Guidelines for Management of Gout has a positive effect.

28 Oct 2013

Lupus disparities: Young, black women have highest rate of developing lupus

Young, black women have the highest rate of developing lupus and are most likely to be diagnosed at a younger age than whites and during childbearing years, according to a new University of Michigan study of lupus in Southeastern Michigan.

25 Oct 2013

ASN strongly recommends all adults to undergo routine screening for chronic kidney disease

The American Society of Nephrology strongly recommends that all adults undergo routine screening for chronic kidney disease (CKD), the 8th leading cause of death in the U.S. This contradicts screening guidelines recently released by the American College of Physicians (ACP).

23 Oct 2013

Astrazeneca, Evotec Launch Kidney Disease Collaboration

...

21 Oct 2013

Researchers discover link between NOX4 enzyme and osteoporosis

Genkyotex, the leading developer of NOX enzyme inhibitors, announced today that a group of collaborators have discovered a link between the enzyme NOX4 and development of osteoporosis.

21 Oct 2013

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.

18 Oct 2013

WHO calls on countries to eliminate lead poisoning that affects children globally

Lead poisoning has devastating health consequences, in particular for children, with childhood lead exposure estimated to contribute to 600 000 new cases of children with intellectual disabilities every year. Overall, 99% of children affected by high exposure to lead live in low- and middle-income countries, says WHO on the occasion of International Lead Poisoning Prevention Week of Action, and calls on countries to strengthen national actions to eliminate lead paint.

18 Oct 2013

High-intensity interval training with Mediterranean diet counselling 'supersizes' heart health

Lifestyle programs focused on high-intensity interval training combined with nutritional counselling on the Mediterranean diet have shown dramatic results for improving the heart health of people with abdominal obesity, finds a study released at the Canadian Cardiovascular Congress.

18 Oct 2013

Dialysis while sleeping improves kidney health and decreases risk of heart disease

Montreal- Receiving dialysis at home while sleeping not only improves kidney health and quality of life for people with kidney disease, it could also decrease their risk of heart disease, says new study presented at the Canadian Cardiovascular Congress.

18 Oct 2013

Diaverum broadens footprint in Saudi Arabia

Diaverum, Europe's largest product independent and one of the world's leading renal care service providers, broadens its footprint in Saudi Arabia by being awarded with a five year contract to run 50 % of the dialysis clinics previously under the management of the state.

16 Oct 2013

Blood pressure reduction supported for early-stage kidney disease

Blood pressure reduction per se, rather than the particular antihypertensive used, reduces the risk for cardiovascular events in patients with chronic kidney disease, shows a meta-analysis published in BMJ.

14 Oct 2013

Children who receive solid-organ transplants have risk of developing advanced kidney disease

Children who undergo transplants of solid organs have a high risk of developing advanced kidney disease, according to a new national study. Among these children, the highest risk is in those receiving lung or intestinal transplants, followed by heart and then liver transplants. The researchers say their findings reinforce the importance of continued screening of kidney function in pediatric transplant recipients.

14 Oct 2013

WHO: Iron deficiency causes loss of 48,225 disability-adjusted life-years worldwide

Data supporting the need for better recognition of iron deficiency will be presented this week at the United European Gastroenterology Week Congress in Berlin. Iron deficiency is frequently under-diagnosed, resulting in increased hospitalisation, reduced quality of life and higher death rates in patients with comorbid conditions. The WHO has estimated that iron deficiency causes the loss of 48,225 disability-adjusted life-years worldwide, more than is seen with lung cancer.

12 Oct 2013

WHO, Health Care without Harm to launch Mercury-Free Healthcare by 2020

WHO and Health Care without Harm have joined forces to launch a new initiative to get mercury removed from all medical measuring devices by 2020.

11 Oct 2013

Less educated, African Americans receive lower quality or marginal kidneys for transplantation

Among younger kidney transplant recipients, a disproportionate number of African Americans and individuals with less education receive organs that are of lower quality or are considered marginal, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The findings suggest that there are racial and social disparities in the allocation of transplanted organs that need to be addressed.

11 Oct 2013

Suppression of mitochondria: A dominant feature of diabetic kidney disease

Researchers at the University of California, San Diego School of Medicine have identified 13 metabolites - small molecules produced by cellular metabolism - that are significantly different in patients with diabetes and chronic kidney disease compared to healthy controls.

11 Oct 2013

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis.

10 Oct 2013

Nephropathy News and Research

Further Reading

REDDSTAR plenary meeting to be held in Berlin on Nov 5 and 6

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

Pharmalink's Busulipo receives FDA orphan drug designation

Study examines role of urate-lowering therapy on renal function in patients with hyperuricemia

Lupus disparities: Young, black women have highest rate of developing lupus

ASN strongly recommends all adults to undergo routine screening for chronic kidney disease

Astrazeneca, Evotec Launch Kidney Disease Collaboration

Researchers discover link between NOX4 enzyme and osteoporosis

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

WHO calls on countries to eliminate lead poisoning that affects children globally

High-intensity interval training with Mediterranean diet counselling 'supersizes' heart health

Dialysis while sleeping improves kidney health and decreases risk of heart disease

Diaverum broadens footprint in Saudi Arabia

Blood pressure reduction supported for early-stage kidney disease

Children who receive solid-organ transplants have risk of developing advanced kidney disease

WHO: Iron deficiency causes loss of 48,225 disability-adjusted life-years worldwide

WHO, Health Care without Harm to launch Mercury-Free Healthcare by 2020

Less educated, African Americans receive lower quality or marginal kidneys for transplantation

Suppression of mitochondria: A dominant feature of diabetic kidney disease

Promedior starts Phase 2 clinical trial to evaluate PRM-151 in patients with myelofibrosis

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News